LTR Pharma Limited (AU:LTP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LTR Pharma Limited is set to hold its Annual General Meeting on 27 November 2024 in Brisbane, where shareholders will have the chance to discuss the company’s innovative nasal spray for Erectile Dysfunction, SPONTAN®. This product is unique due to its rapid intranasal delivery, promising quick results for users, highlighting LTR Pharma’s commitment to improving men’s health.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.